• Equity Capital Markets
  • Debt Capital Markets
  • Private Capital Advisory
  • Mergers & Acquisitions


  • Healthcare


Jason Henke is a Director of Healthcare & Life Sciences Investment Banking at B. Riley Securities. He has over 15 years of experience in the healthcare industry across strategy, operations, and M&A transaction execution for healthcare companies.

Prior to joining B. Riley Securities, Mr. Henke was a Director at Huron Transaction Advisory LLC, an investment bank within Huron Consulting Group (NASDAQ: HURN). Prior to his time at Huron, Mr. Henke was a Director of Healthcare M&A at a boutique investment bank executing transactions across healthcare services. Mr. Henke has led strategic engagements with some of the largest payor and provider organizations nationally as a member of the Health Industries Group at PricewaterhouseCoopers (PwC).

He holds a Master of Business Administration from the Leonard N. Stern School of Business at New York University and a Bachelor of Science from St. John's University in Queens, NY. He is a FINRA registered securities representative with Series 63, SIE and 79 licenses.

Mr. Henke has advised and executed transactions across several sub-sectors of healthcare including physician practice management, behavioral health, HCIT, pharma/life sciences and tech-enabled healthcare services.

B. Riley Securities provides a full suite of investment banking, corporate finance, advisory, research, and sales and trading services. Investment banking services include initial, secondary and follow-on offerings, institutional private placements, merger and acquisition (M&A) advisory, SPACs, corporate restructuring and recapitalization. B. Riley is nationally recognized and highly ranked for its proprietary small-cap equity research. B. Riley Securities formerly operated as B. Riley FBR following the merger of B. Riley & Co. and FBR & Co.